Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03680924 · ClinicalTrials.gov registry record
Access to Resources for Patients With PTEN Hamartoma Tumor Syndrome
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 13
- Enrollment target
NCT03680924 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 13 participants.
The verdict
NCT03680924 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to gain a better understanding of access to clinical and research resources for families of children affected with a phosphatase and tensin homology (PTEN) mutation. Ultimately, the researchers hope to be able to use this information to develop a standard of care for affected individuals and their family members. Family members/legal guardians of an individual with a PTEN mutation enrolled in the Rare Diseases Clinical Research Network (RDCRN) Contact Registry will be invited via email to participate in this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-05-11 |
| Est. Completion | 2019-09-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03680924
The ClinicalTrials.gov registry entry for NCT03680924 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03680924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03680924 about?
NCT03680924 is a clinical study titled "Access to Resources for Patients With PTEN Hamartoma Tumor Syndrome". The purpose of this study is to gain a better understanding of access to clinical and research resources for families of children affected with a phosphatase and tensin homology (PTEN) mutation. Ultimately, the researchers hope to be able to use this information to develop a standard of care for aff...
What is the current status of trial NCT03680924?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2018-05-11. Estimated completion is 2019-09-13.
Who is sponsoring clinical trial NCT03680924?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.